DDI Seed Grant Program: Request for Applications

The UH Drug Discovery Institute (DDI) aims to advance academic drug discovery through multi-disciplinary collaborations, integrating new technologies to streamline and augment drug discovery and development at UH.

The purpose of this program is to catalyze multidisciplinary research teams with seed funds that would facilitate preparation and submission of competitive extramural drug discovery and development research proposals. The seed funding grant program supports the University thrust for Drug Discovery and Development that the Vice President for Research and the Provost developed in consultation with the college deans, and which the Chancellor has endorsed. This seed grant program is also aimed at supporting the UH Strategic Plan.

Each application responding to this RFA should be submitted by an interdisciplinary research team with principal investigators from at least two different colleges, aiming at building university-wide capabilities in new drug discovery and development. 

ELIGIBILITY: Full-time University of Houston faculty members (tenured, tenure-track, or non-tenure-track research/clinical faculty) are eligible to apply. Other investigators employed by UH may be listed as co-investigators.

FUNDING AMOUNT: For this fiscal year, we anticipate making three to four awards ranging from $40,000-$70,000, up to a total of $250,000. The funding period is up to 18 months, with a starting date of June 1, 2023.

DURATION: 18 months

All questions related to this program should be submitted to DDI coordinator Nadine Peterson at nhpeter2@cougarnet.uh.edu.